Publicações

Follow-Up Extension Study of a Double-Blind Phase 3 Clinical Study of Recombinant Human Arylsulfatase B in Patients with Mucopolysaccharidosis Vi

AuthID
P-000-4KE

Author(s)

Harmatz, P

Giugliani, R

Schwartz, I

Guffon, N

Miranda, CS

Teles, E

Wraith, JE

Beck, M

Hopwood, J

Swiedler, S

Document Type

Abstract

Year published

2005

Published

in MOLECULAR GENETICS AND METABOLISM, ISSN: 1096-7192

Volume: 84, Issue: 3, Pages: 237-238 (2)

Conference

Annual Meeting of the Society-For-Inherited-Metabolic-Disorders (Simd 2005), Date: MAR 06-09, 2005, Location: Pacific Grove, CA, Sponsors: Genzyme Corp, Mead Johnson Nutr, NIDDK, NIH, Off Rare Dis, Dept Hlth & Human Serv, Ucyclyd Pharma, Actelion Pharmaceut US Inc, Abbott Labs, Ross Prod Div, SHS N Amer, Appl Biosyst, Appl Nutr Corp, BioMarin Pharmaceut Inc, Milupa N Amer, Vitaflo, Biochrom Inc, Cambrooke Foods, Hitachi High Technologies Amer Inc, Natl Urea Cycle Defects Fdn, Pickering Labs Inc, Rare Dis Therapeut Inc, Sigma Tau Pharmaceut, Transkarot Therapies Inc

Indexing